CNTA 8-K 2026-06-24

Centessa Pharmaceuticals plc (CNTA) 8-K dated 2026-06-24 — accession 0001193125-26-280337. This URL is the filing, not the CNTA hub.

Centessa Pharmaceuticals plc (CNTA) is a biotechnology company listed on US.

Centessa Pharmaceuticals plc filed a 8-K on 2026-06-24. Accession 0001193125-26-280337.

Cached items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.

Not investment advice. The CNTA SEC hub lists recent forms. The stock page is the research view.